Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team.
about
Enrolling women into HIV preventive vaccine trials: an ethical imperative but a logistical challenge.Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical preventionAssessing the feasibility of hepatitis C virus vaccine trials: results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness study.Enhanced retention strategies and willingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials.Increased hepatitis C virus vaccine clinical trial literacy following a brief intervention among people who inject drugs.HIV vaccine trial willingness among injection and non-injection drug users in two urban centres, Barcelona and San Francisco.Enhancing HIV vaccine trial consent preparedness among street drug usersIn "Step" with HIV Vaccines? A Content Analysis of Local Recruitment Campaigns for an International HIV Vaccine StudyPromoting HIV Vaccine Research in African American Communities: Does the Theory of Reasoned Action Explain Potential Outcomes of Involvement?An extended model of reasoned action to understand the influence of individual- and network-level factors on African Americans' participation in HIV vaccine research.The likelihood of participation in clinical trials can be measured: the Clinical Research Involvement Scales.The potential role of biomarkers in HIV preventive vaccine trialsAre young injection drug users ready and willing to participate in preventive HCV vaccine trials?A randomized trial of enhanced HIV risk-reduction and vaccine trial education interventions among HIV-negative, high-risk women who use noninjection drugs: the UNITY studyEnrollment in YFV Vaccine Trial: An Evaluation of Recruitment Outcomes Associated with a Randomized Controlled Double-Blind Trial of a Live Attenuated Yellow Fever Vaccine.HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria.Project VOGUE: A partnership for increasing HIV knowledge and HIV vaccine trial awareness among House Ball leaders in Western New York."Once Bitten, Twice Shy": participant perspectives in the aftermath of an early HIV vaccine trial termination.Socio-behaviour challenges to phase III HIV vaccine trials in Sub-Saharan Africa.Engaging members of African American and Latino communities in preventive HIV vaccine trials.Towards a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials: An Embedded Four-Country Case Study.Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-positive injection drug users.Factors associated with willingness to participate in a pharmacologic addiction treatment clinical trial among people who use drugsWillingness to participate in future HIV prevention studies among gay and bisexual men in Scotland, UK: a challenge for intervention trials.Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-negative injection drug usersCharacteristics of female sex workers in southern India willing and unwilling to participate in a placebo gel trialUnderstanding differences in enrollment outcomes among high-risk populations recruited to a phase IIb HIV vaccine trial.Factors influencing HIV vaccine community engagement in the urban South.Predicting hypothetical willingness to participate (WTP) in a future phase III HIV vaccine trial among high-risk adolescents.Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: results of a national survey.Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users.
P2860
Q25255907-225C8B6A-50A8-4A6B-A841-754373D58CD8Q30206105-236838F1-3E90-4A49-908F-6D0982F790D9Q30208996-9BC40C2B-0C15-48F1-9651-40EEE3AFC229Q30223510-560D71B1-0970-40B5-975E-5B6A0912F208Q30223906-6DB0FFCF-0972-40F5-853A-9710600213D5Q30226766-45C9588B-105E-4525-AD32-09A15987BD0FQ30227101-9283011E-AB0D-4A8B-9796-E6CF8A9795D2Q30378981-35C36D2C-8C97-441D-8893-3389905B1279Q30392323-4A00A4E4-AB68-4814-B05B-A7ABBDC29BD4Q33807022-C3AEDFF5-B7DF-4EC6-A72C-3DCD3CA0EC83Q33941271-7C45DA65-BBFD-43D4-93A9-0A4CDECF5421Q34059957-CDCEDF4C-9DE8-4068-8FA5-4D395355ECD7Q34115061-10C6937C-1449-496D-A1AC-897934DB86BDQ34133358-373B47B0-23A4-4E1A-AE05-E6C903B8D7B0Q34159806-FBC1EAC2-8B4D-419A-BF29-F7C384809E4AQ34313611-0F52C34F-C659-4B37-A47C-92EADF58C755Q35019252-00C856B8-6B6C-4570-ABFA-2BE1B044EC57Q35219438-9022CAA2-46DE-47A9-8AAD-FB4CE5D5FAF1Q35698044-39D637E3-C5E6-47F4-B05D-0D24C0AE5E5BQ35736408-D7D55C9B-88BD-4C7A-997D-FA486E4B0EFBQ35752023-34969140-1A0D-41B7-B655-D99F97D99B8FQ35791291-6DEA3509-41DA-4158-A826-B777C74D4865Q36079296-D50361EF-0E70-41BF-90A6-837EA0AD1449Q36106497-92DB9713-B802-4ADF-90A1-4E49663A1491Q36283432-8B173F65-A19A-4D21-9460-3B2C3E1E54B9Q36777020-2E4D046A-A756-441D-8452-B016EEB5F549Q36853358-E4E4EB04-6B9B-4C66-A3C0-4081C12F0C86Q39841959-A99D51AB-ECE5-4CF7-9DDF-1012AFCAF15BQ40187770-ADB248F5-A3D7-4EAB-93C0-7154858A6D6AQ40373488-D665708B-7804-4B68-8F0E-E01D5A7FB74DQ40398638-B35C4B42-4B95-4C7F-915F-4C431A3A8DFF
P2860
Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Readiness for HIV vaccine tria ...... paredness Study Protocol Team.
@ast
Readiness for HIV vaccine tria ...... paredness Study Protocol Team.
@en
type
label
Readiness for HIV vaccine tria ...... paredness Study Protocol Team.
@ast
Readiness for HIV vaccine tria ...... paredness Study Protocol Team.
@en
prefLabel
Readiness for HIV vaccine tria ...... paredness Study Protocol Team.
@ast
Readiness for HIV vaccine tria ...... paredness Study Protocol Team.
@en
P2093
P1476
Readiness for HIV vaccine tria ...... paredness Study Protocol Team.
@en
P2093
P304
P356
10.1097/00126334-200008150-00010
P407
P577
2000-08-01T00:00:00Z